Beacon Investment Advisory Services Inc. Sells 58,696 Shares of Kenvue Inc. $KVUE

Beacon Investment Advisory Services Inc. reduced its position in shares of Kenvue Inc. (NYSE:KVUE) by 12.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 408,412 shares of the company’s stock after selling 58,696 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in Kenvue were worth $7,045,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. CIBRA Capital Ltd bought a new stake in Kenvue during the fourth quarter valued at about $2,139,000. Global X Japan Co. Ltd. increased its stake in shares of Kenvue by 37.7% in the fourth quarter. Global X Japan Co. Ltd. now owns 38,579 shares of the company’s stock worth $665,000 after purchasing an additional 10,557 shares during the period. Mather Group LLC. increased its stake in shares of Kenvue by 122.8% in the fourth quarter. Mather Group LLC. now owns 67,206 shares of the company’s stock worth $1,159,000 after purchasing an additional 37,037 shares during the period. Butensky & Cohen Financial Security Inc. lifted its position in shares of Kenvue by 4.5% during the 4th quarter. Butensky & Cohen Financial Security Inc. now owns 223,228 shares of the company’s stock worth $3,851,000 after purchasing an additional 9,704 shares during the last quarter. Finally, Norden Group LLC bought a new stake in Kenvue during the 4th quarter valued at approximately $689,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Canaccord Genuity Group upped their price target on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Barclays raised their price objective on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Friday, March 6th. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and dropped their target price for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Finally, Argus upgraded shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $19.58.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $17.52 on Monday. The firm has a market capitalization of $33.57 billion, a price-to-earnings ratio of 22.75, a PEG ratio of 3.98 and a beta of 0.51. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The business has a fifty day simple moving average of $18.01 and a 200 day simple moving average of $17.12. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. During the same quarter in the previous year, the firm posted $0.26 EPS. The business’s revenue for the quarter was up 3.2% on a year-over-year basis. Sell-side analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. Kenvue’s payout ratio is presently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.